Phase I Study of ACTR087, Autologous T Lymphocytes Expressing Antibody Couple T-Cell Receptors (CD16V-41BB-CD35), in Combination with Rituximab, in Subjects with Relapsed or Refractory CD20-Positive B-Cell Lymphoma